Arena Pharmaceuticals, Inc. / Products

    { "items": [ { "from": "Collaboration And Other Revenue", "to": "Net revenue", "flow": 54000, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "License", "to": "Net revenue", "flow": 0, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "Royalty", "to": "Net revenue", "flow": 0, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "Net revenue", "to": "Cost of goods sold", "flow": 0, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "Net revenue", "to": "Gross profit", "flow": 46523.64952184027, "colorFrom": "#1d6a54", "colorTo": "#1d6a54" }, { "from": "Gross profit", "to": "R&D expenses", "flow": 361427586.8010683, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "Gross profit", "to": "SG&A expenses", "flow": 108727492.03067115, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "Net loss", "to": "EBITDA", "flow": 525092616.5245111, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "EBITDA", "to": "D&A", "flow": 3335917.980528991, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "Net loss", "to": "EBITDA", "flow": 538876540.018954, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "Tax credits", "to": "Net income", "flow": 346342.7242181442, "colorFrom": "#1d6a54", "colorTo": "#1d6a54" } ], "priority": [ "Net loss", "Tax credits", "Other income", "Net income", "EBIT", "EBITDA", "Gross profit", "Net revenue", "Collaboration And Other Revenue", "License", "Royalty", "Cost of goods sold", "R&D expenses", "SG&A expenses", "D&A", "Tax expenses" ] }
    Product Revenue
    Collaboration And Other Revenue €54.00K 116.1%
    License €0.00 0.0%
    Royalty €0.00 0.0%

    Notifications